
COVID-19 Funding Opportunities
ORSP has identified the following funding opportunities related to COVID-19. If interested, please submit an NOI: research.utep.edu/noi
UTEP invites researchers are to submit COVID-19 related research proposals to the consortium, which will then be reviewed for matching with computing resources. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. The COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus. Applications are accepted at any time.
Agency | Program | Due Date | Abstract | Type |
---|---|---|---|---|
United States Department of Health and Human Services (HHS) |
Biomedical Advanced Research and Development Authority (BARDA) Novel Coronavirus EZ-BAA |
Rolling | Seeks research for molecular diagnostic assays, point-of-care detection, screening models, and other topics pertaining to COVID-19. | FED |
Centers for Disease Control and Prevention (CDC) | 12/18/2020 |
The CDC has announced a funding opportunity to develop and implement an influenza-like illness (ILI)-specific student absentee monitoring system in kindergarten through twelfth grade (K-12) schools and assess its usability for early detection of influenza, SARS-CoV-2, and other respiratory pathogen transmission in schools and surrounding communities. Topics: Applicants must propose a project that includes the following tasks:
|
FED | |
White House Office of Science and Technology Policy |
This consortium is a unique private-public effort to bring together federal government, industry, and academic leaders to execute complex computational research programs. Researchers are invited to submit COVID-19 related research proposals to the consortium via this online portal, which will then be reviewed for matching with computing resources from one of the partner institutions. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. |
FED | ||
Food and Drug Administration (FDA)/Office of the Chief Scientist (OCS) |
The Food and Drug Administration (FDA) Office of the Chief Scientist (OCS) and FDA Center for Drug Evaluation and Research (CDER), Office of Medical Policy (OMP) is announcing its intent to accept and consider applications for the award of a co-operative agreement to protect and promote the health of the American public by creating new, applied scientific knowledge, tools, standards and approaches to evaluate products more effectively, predictably and efficiently. |
FED | ||
National Endowment for the Humanities (NEH) |
Funding for NEH Applicants and Grantees Impacted by the Coronavirus |
|
FED | |
Office of the Assistant Secretary for Preparedness and Response (ASPR) |
Public Health Emergency development of new medical countermeasures |
Public Health Emergency development of new medical countermeasures |
FED | |
National Institutes of Health (NIH) Agency for Healthcare Research and Quality (AHRQ) |
The health systems research community should prepare to submit applications to AHRQ to fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19, effects on quality, safety, and value of health system response to COVID-19, and the role of primary care practices and professionals during the COVID-19 epidemic. AHRQ is particularly interested in understanding how digital health innovations contributed to health system and healthcare professional innovation and challenges and solutions to meeting the needs of vulnerable populations including older adults, people living with multiple chronic conditions, rural communities, and uninsured and underinsured populations. |
SUPPL | ||
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) |
03/25/2021 |
This supports research on coronavirus disease with a particular focus on viral natural history, pathogenicity and transmission. The maximum project duration is two year |
SUPPL | |
National Institutes of Health (NIH) |
11/10/2020 |
The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the need for projects that address the coronavirus disease 2019 (COVID-19) Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. NCATS is soliciting applications for Administrative Supplements (through PA-18-591) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients. |
SUPPL | |
National Institutes of Health (NIH) |
Rolling, through 05/01/2021 |
NIA – Mission critical areas as they relate to the COVID-19 pandemic. NIMH – Applications addressing care for new or worsening mental health needs and/or suicide risk in midlife and older age adults will be seen as a high priority.
|
SUPPL | |
National Institutes of Health (NIH) |
To be announced |
The purpose of this Notice is to extend the data-harmonization effort at the National Institute of Mental Health (NIMH) announced in NOT-MH-15-009 to research protocols pertaining to the public health emergency caused by Coronavirus Disease 2019 (COVID-19), the disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). |
SUPPL | |
National Institutes of Health (NIH) |
05/01/2021 |
|
SUPPL | |
National Institutes of Health (NIH) |
Varies by program |
Three of the largest NIH parent/umbrella funding mechanisms have now been updated to indicate that applications pertaining to COVID-19 research are welcomed. |
FED | |
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) |
NOSI regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | Rolling, through 03/25/2021 |
Topics: Viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19. | FED |
National Institutes of Health (NIH) | 12/01/2020 | This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups. | FED | |
National Institutes of Health (NIH) | Rolling | The National Institute of Allergy and Infectious Diseases (NIAID) has released a new funding opportunity to provide personal protective equipment to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID’s emergency appropriation provided by the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 and the Coronavirus Aid, Relief and Economic Security (CARES) Act. | FED | |
National Institutes of Health (NIH) | 11/16/2020 | The purpose of this program is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological, and hematologic tissues and diseases. | FED | |
National Institutes of Health (NIH) |
|
05/08/2023 |
Topics: Areas of interest of this NOSI include, but are not limited to:
|
FED |
National Institutes of Health (NIH) | 05/08/2023 |
Topics: The specific areas of interest of each participating institute or center are listed in the NOSI (see link), but in general, proposals are solicited for projects addressing the following research objectives:
|
||
National Institutes of Health (NIH) | 12/02/2020; 03/02/2021 |
The NIH has announced a funding opportunity focusing on the role and impact of digital health interventions, (e.g., mobile health [mhealth], telemedicine and telehealth, health information technology [IT], and wearable devices) to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the COVID-19 pandemic, particularly in populations that experience health disparities and vulnerable populations. | FED | |
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) |
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) | 02/06/2021 | Topics: NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV. NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens. |
FED |
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) |
02/02/2021 |
This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19). Applications on the following priority topics are invited:
|
FED | |
National Institutes of Health (NIH) | 01/24/2021 |
Description: The National Center for Advancing Translational Sciences has released an urgent U01 funding opportunity announcement to invite applications to repurpose existing therapeutic agents to treat COVID-19 sequelae and associated complications that result from SARS-CoV-2 infections. The therapeutic agent must have already completed at least a Phase I clinical trial for a different indication, and not require additional regulatory studies for the new indication prior to starting a clinical trial. Topics: Clinical trials of existing therapeutic agents for treating COVID-19 |
FED | |
National Institutes of Health (NIH) |
|
11/10/2020 |
The National Center for Advancing Translational Sciences (NCATS) has issued a Notice of Special Interest to solicit applications for Administrative Supplements from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients to address COVID-19. Topics: See the funding opportunity announcement for details of the topics that are specific to UL1 and U24 awards. |
FED |
National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) |
NOSI regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 | Rolling, through 02/06/2021 | Topics: Predictive models for the spread of SARS-CoV-2 and other related infectious agents (all relevant grants). Repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection; rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR grants only). | FED |
National Institutes of Health (NIH) |
|
12/15/2020 | Topics: This NOSI highlights interest in research to strengthen the healthcare response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. While the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this NOSI is to support research to address secondary health effects of the social, behavioral, and economic changes, particularly among populations who experience health disparities and vulnerable populations through the use of digital health assessments and interventions to yield measurable near-term impact. | FED |
National Institutes of Health (NIH) | 02/05/2021 | Seeks projects to develop predictive models for disease spread; tools for rapid detection; and rapid development of therapeutic agents. | SUPPL | |
National Institutes of Health (NIH) | 12/15/2020 | Topics: Projects may evaluate existing or ongoing community-based programs or policies (i.e., natural experiments), or prospectively test new or adapted interventions. Multilevel interventions that do not solely target individuals, but also address the upstream determinants that influence individual functioning and health outcomes are strongly encouraged. Projects should be designed to test hypotheses about mechanisms of action that account for an intervention’s effects; mechanisms may operate at any level of analysis.
Key questions include: To what extent do existing interventions slow the spread of COVID-19 in specific populations and geographic hotspots? To what extent do policies, guidelines, and other interventions facilitate adherence and mitigate the multifaceted impacts of COVID-19 on health in populations that experience health disparities and vulnerable groups? Can established models of crisis and disaster response and management be applied to address the needs of health disparity and other vulnerable populations? |
FED | |
National Institutes of Health (NIH) |
03/30/2021 |
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). The NIBIB is seeking applications to develop life-saving technologies that can be ready for commercialization within one to two years |
FED | |
National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) |
03/08/2021, 07/09/2021 |
Topics: Use of informatics solutions to diagnose cases and the use of CTSA-supported core resources to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines.
|
FED | |
National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) |
10/16/2020 |
Topics: Using innovative processes to identify the therapeutic/indication pair for use to treat COVID-19.
|
SUPPL | |
National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering (NIBIB) |
11/10/2020 |
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). The NIBIB is seeking applications from current grantees to develop life-saving technologies that can be ready for commercialization within one to two years. |
FED | |
National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) |
11/10/2020 |
This supports projects in translational science that address the COVID-19 public health emergency. Up to 40 awards are available. Supplement grants are generally for a maximum period of one year |
SUPPL | |
National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) |
11/10/2020 |
Topics:
|
SUPPL | |
National Institutes of Health (NIH) National Institute of Drug Abuse (NIDA) |
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | Rolling, through 03/31/2021 | NIDA is interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders. | SUPPL |
National Institutes of Health (NIH) |
This Special Emphasis Notice (SEN) highlights AHRQ’s interest in receiving applications focusing on primary and other ambulatory care settings that: 1) test approaches to integrating organizational health literacy strategies that make it easier for people, especially those with limited health literacy, to take action to prevent and manage their chronic conditions, including diabetes, and 2) spread and scale previously tested organizational health literacy strategies to settings that serve a high proportion of patients with limited health literacy, and/or socioeconomically disadvantaged people.AHRQ is interested in applications that address:
|
FED | ||
National Institutes of Health (NIH) |
|
05/03/2021 |
This supports research aimed at understanding the impact of environmental exposures on coronavirus disease and its causative agent. Funding may last for up to two years. |
FED |
National Institutes of Health (NIH) |
05/03/2021 |
NIEHS is issuing this Notice of Special Interest (NOSI) to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). NIEHS is particularly interested in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies. |
FED | |
National Institutes of Health (NIH) |
Rolling, through 04/30/2021 |
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). |
FED | |
National Institutes of Health (NIH) |
NIH Rapid Acceleration of Diagnostics (RADx) Initiative for COVID-19 |
Rolling |
The stimulus investment supercharges NIH’s strong research efforts already underway focused on prevention and treatment of COVID-19, including the recently announced planned Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership to coordinate the international research response to the pandemic. As part of this initiative, NIH is urging all scientists and inventors with a rapid testing technology to compete in a national COVID-19 testing challenge for a share of up to $500 million over all phases of development. The technologies will be put through a highly competitive, rapid three-phase selection process to identify the best candidates for at-home or point-of-care tests for COVID-19. |
FED |
National Institutes of Health (NIH) |
Rolling, through 04/30/2021 |
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19). |
FED | |
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) |
04/31/2021 |
These support research projects focusing on obtaining time-sensitive data to better understand key aspects of severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019. Application budgets are limited to USD 275,000 for two years. |
FED | |
National Institutes of Health (NIH) |
03/02/2021 |
While research related to the direct clinical effects of COVID-19 are supported by other funding opportunities, the purpose of this funding opportunity is to focus on the role and impact of digital health interventions [e.g., mobile health (mhealth), telemedicine and telehealth, health information technology (IT), and wearable devices] to address access, reach, delivery, effectiveness, scalability and sustainability of health assessments and interventions for secondary effects (e.g., behavioral health or self-management of chronic conditions) that are utilized during and following the pandemic, particularly in populations who experience health disparities and vulnerable populations |
FED | |
National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) |
These support research on SARS-CoV-2 and COVID-19. The maximum project period is five years. |
FED | ||
National Institutes of Health (NIH) National Center for Advancing Translational Sciences(NCATS) |
|
Rolling through 01/25/2021 |
NCATS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the COVID-19. NCATS is especially interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines. This Notice announces the availability of competitive revisions for investigators and institutions funded through:
|
SUPPL |
National Institutes of Health (NIH) National Center for Advancing Translational Sciences(NCATS) |
01/02/2022 |
NCATS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the COVID-19. NCATS is especially interested in research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines. |
SUPPL | |
National Institutes of Health (NIH) National Center for Advancing Translational Sciences(NCATS) |
|
Rolling through 11/11/2020 | NCATS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. NCATS is soliciting applications for Administrative Supplements (through PA-18-591) and Emergency Competitive Revisions (through PA-20-135) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients | SUPPL |
National Institutes of Health (NIH) National Cancer Institute (NCI) |
The National Cancer Institute (NCI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa. Topics of specific interest to NCI include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer. | FED | ||
National Institutes of Health (NIH) National Cancer Institute (NCI) |
Rolling through 01/25/2021 |
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Cancer Institute (NCI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for the development of prophylactic, therapeutic and diagnostic for Coronavirus Disease 2019 (COVID-19). To accelerate the development of promising technologies, the NCI encourages applications from small businesses with NCI-funded active SBIR/STTR awards for technologies that have a strong potential to be adapted/repurposed for use as a prophylactic, therapeutic or diagnostic tool for SARS-CoV-2 (COVID-19). |
SUPPL | |
National Institutes of Health (NIH) | Rolling through 03/31/2021 |
This Notice of Special Interest (NOSI) highlights the urgent need for social, behavioral, economic, health communication, and epidemiologic research relevant to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19. This NOSI encourages urgent competitive supplements and administrative supplements to existing longitudinal studies that address key social and behavioral questions related to the COVID-19 pandemic, including adherence to and transmission mitigation from various containment and mitigation efforts; social, behavioral, and economic impacts from these containment and mitigation efforts; and downstream health impacts resulting from these social, behavioral, and economic impacts,including differences in risk and resiliency based on gender, race and ethnicity, socioeconomic status, and other social determinants of health. |
SUPPL | |
National Institutes of Health (NIH) | Rolling through 04/14/2021 |
NINDS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects on the nervous system of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Research of interest must fall within NINDS’s scientific mission, which is to support basic, translational, and clinical neuroscience research to expand fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. In order to rapidly improve our understanding of the neurological consequences of infection of SARS-CoV-2 and of COVID-19, NINDS is encouraging the submission of applications for supplements to address the biology, pathophysiology, prevention, diagnosis, sequelae, or treatment of the 2019 Novel Coronovirus that are directly related to the NINDS mission. |
SUPPL | |
National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
04/15/2021 |
This supports research on the impact of alcohol as a biological contributor to COVID-19 outcomes in order to enhance the response to the pandemic and better respond to future public health emergencies. Budgets are worth up to USD 100,000 in direct costs per year for up to two years. |
SUPPL | |
National Institutes of Health (NIH) National Institute of Mental Health (NIMH) |
04/15/2021 |
NIMH is issuing this Notice of Special Interest (NOSI) to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. NIMH is especially interested in research to provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest to NIMH. |
SUPPL | |
National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
Rolling through 04/15/2021 |
NIAAA is encouraging research in the following areas, including those that capitalize on existing research cohorts, to investigate urgent research questions of significance to the COVID-19 pandemic within the general population and among underserved populations, such as racial, ethnic and gender minorities, individuals with low socioeconomic status, and those who are incarcerated or homeless. |
FED | |
Agency for Health Care Research and Quality (AHRQ) |
Competitive Revision Supplements to Existing AHRQ Health Service Research (HSR) Grants and Cooperative Agreements to Evaluate Health System and Healthcare Professional Responsiveness to COVID-19 (Supplement – Clinical Trial Optional) |
Varies |
For grants that were previously funded under FOAs supported by Patient Centered Outcome Research Trust Fund (PCOR TF) dollars, please see FOA number PA-20-072. For grants that were funded using AHRQ Health Service Research (HSR) dollars, please see FOA number PA-20-070. Topics: Applications must be responsive to AHRQ’s mission. AHRQ’s Research Priority Areas are:
|
SUPPL |
National Science Foundation (NSF) |
Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19 | Rolling |
NSF is seeking Phase I SBIR/STTR proposals focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. Topics: Artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. |
FED |
National Science Foundation (NSF) |
Rolling |
The NSF encourages investigators to use existing NSF funding mechanisms to submit proposals to conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.For proposals of up to $200K, NSF encourages using the Rapid Response Research (RAPID) funding mechanism, which allows NSF to receive and review proposals having a severe urgency. |
FED | |
National Science Foundation (NSF) | Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) | Rolling |
The Office of Advanced Cyberinfrastructure (OAC) within the Directorate for Computer and Information Science and Engineering is inviting RAPID proposals and supplemental funding requests to existing awards that address COVID-19 challenges through data and/or software infrastructure development activities. |
FED |
Department of Commerce (DOC) National Institute of Standards and Technology (NIST) |
NIST Manufacturing USA National Emergency Assistance Program | Rolling |
Topic: NIST invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic |
FED |
Department of Defense (DOD) |
Congressionally Directed Medical Research Programs (CDMRP) | Varies
|
Three of the FY20 PRMRP mechanisms are focused on Emerging Viral Diseases and Respiratory Health. Mechanisms: |
FED |
Department of Defense (DOD) Medical Technology Enterprise Consortium (MTEC) |
To be announced |
MTEC is an enterprise partnership in collaboration with industry and academia to facilitate research and development activities, in cooperation with the U.S. Army Medical Research and Development Command (USAMRDC) and other DoD agencies in the biomedical sciences MTEC membership is not required for proposal submission, but it is required for an award. |
FED | |
Department of Defense (DOD) Medical Technology Enterprise Consortium (MTEC) |
National Emergency Telecritical Care Network (NETCCN) Project | To be announced |
This program is specifically focused on preparation for COVID-19 related critical care capability shortages. Although the United States has more critical care beds per capita than other developed nations, emerging national and international experience with COVID-19-related critical illness suggests a high level of oncoming system stress on critical care resources and a likely potential for intensive care unit (ICU) beds and care teams to be overwhelmed.
|
FED |
Department of Energy (DOE) |
DOE COVID-19 Response Letter | DOE encourages you to consider scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. Please send research questions that the scientific community may address with DOE resources by email to SC.DCL@science.doe.gov. More information can be found in the Dear Colleague Letter on DOE’s Coronavirus Resources Hub. | FED | |
Department of Energy (DOE) |
COVID-19 High Performance Computing Consortium | Rolling | Invites researchers are to submit COVID-19 related research proposals to the consortium, which will then be reviewed for matching with computing resources. An expert panel comprised of top scientists and computing researchers will work with proposers to assess the public health benefit of the work, with emphasis on projects that can ensure rapid results. The COVID-19 High Performance Computing Consortium helps aggregate computing capabilities from the world's most powerful and advanced computers to help COVID-19 researchers execute complex computational research programs to help fight the virus. | FED |
US Department of Agriculture (USDA) |
National Institute of Food and Agriculture (NIFA) | Varies | In response to the current need for more COVID-19 information, certain NIFA programs will allow submission of COVID-19 relevant projects outside of their normal deadlines. Frequently Asked Questions regarding COVID-19 submissions can be found below. | FED |
US Department of Agriculture (USDA) | Agriculture and Food Research Initiative (AFRI) | Varies |
Topics: Focus areas of interest include, but are not limited to the following:
|
FED |
U.S Agency for International Development (USAID) | Bangladesh and the Private Sector: Partnering to Fight COVID-19 | Rolling, through 04/29/2021 |
This Annual Program Statement (APS) is designed to describe and provide a process through which organizations can work with USAID and the private sector to build GDAs that: a) respond to the current outbreak of COVID-19 in Bangladesh; b) address important business interests and objectives; and c) advance USAID’s strategic priorities and objectives. |
FED |
National Institute of Standards and Technology (NIST) |
NIST Manufacturing USA National Emergency Assistance Program | Rolling | Projects should focus on responding to the COVID-19 pandemic. Projects may include medical countermeasures; non-medical countermeasures; leveraging institute capabilities to strengthen state and community resilience; grants to companies and technical support to accelerate productions of critical materials, equipment, and supplies; creation of additional production facilities; technology roadmapping for pandemic response and recovery; reshoring the manufacture of critical conventional drugs and ensuring supply chain for critical materials related to pandemic response; or workforce development and training for a skilled advanced manufacturing workforce. | FNDN |
Bill & Melinda Gates Foundation |
COVID-19 Therapeutics Accelerator |
The COVID-19 Therapeutics Accelerator is a collaborative effort to research, develop and bring effective treatments to market quickly and accessibly.Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and no proven treatments approved for use against COVID-19. The COVID-19 Therapeutics Accelerator is a philanthropic initiative designed to coordinate R&D efforts, remove barriers to drug development and scale up treatments to address the pandemic.We can combat COVID-19 together. Sharing knowledge and resources across governments, the private sector, academia and philanthropy can accelerate the timeline for bringing treatments to market. We are actively seeking and welcoming new partners and collaborators in this effort |
FNDN | |
American Heart Association (AHA) |
04/06/2021 |
Coronavirus infection (coronavirus disease, COVID-19) shows no signs of abating soon. There is an urgent need to better understand the pathobiology and the clinical implications of the viral infection that leads to the morbidity and mortality seen with COVID-19. |
FNDN | |
LifeArc |
|
04/06/2021 |
LifeArc invites applications for its coronavirus therapeutics call. This supports the identification of therapeutics that can be rapidly deployed to treat COVID-19. The aim is to run trials in patients during the current epidemic. The primary purpose is to accelerate availability of treatments for patients and it is therefore expected that applicants will already have material available for testing and a plan for rapid scale up of clinical material. Priority will be given to projects that have a clear path and availability for patients in a 6-12 month timeframe. |
|
California Institute for Regenerative Medicine |
Special Call for COVID-19 Projects | Rolling, Bi-monthly |
Topics: Discovery, preclinical, and clinical trial stage projects that could quickly advance treatments to COVID-19 patients in need. |
FNDN |
Emergent Ventures |
Fast Grants | Rolling |
Fast Grants are available exclusively to PIs at academic institutions already working on COVID-19 related projects that could help with the pandemic within the next six months. Topics: All COVID-19 related science |
FNDN |
Wellcome Trust |
Epidemic Preparedness - COVID-19 funding call | To be announced |
Wellcome, in partnership with the Department for International Development, invites expressions of interest for its epidemic preparedness - COVID-19 funding call. This aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and increase research and response capacity. |
FNDN |
Open Society Foundations |
To be announced |
The Open Society Foundations are making an investment to combat the devastation in the wake of the coronavirus—focusing on communities too often left out and left back by government policy. |
FNDN | |
Andy Hill CARE Fund |
11/13/2020 |
To address the problem of limited access to cancer prevention and screening during the COVID-19 pandemic, the Andy Hill CARE Fund seeks to support research projects based in Washington State that focus on the impact of COVID-19 on outcomes, research, risks, or well-being for cancer patients. Topics: Examples of areas of research related to COVID-19’s impacts related to cancer include, but are not limited to:
|
FNDN | |
American Documentary | COVID-19 Artist Emergency Fund | Rolling |
This COVID-19 Artist Emergency Fund will provide rapid response grants up to $500 to assist artists with basic needs including food, immediate health needs and insurance premiums. Applications are now open and will be reviewed on a rolling basis until the fund is expired. These one-time grants are a direct response to concerns about sustainability in the documentary field, with overall lack of adequate healthcare alongside loss of livelihood due to canceled production, festivals and theatricals. |
FNDN |
Home Grown |
As our nation faces the COVID-19 pandemic, the importance of home-based child care has never been more evident and these caregivers and providers have never been more indispensable. We cannot fight this pandemic without ensuring that the essential workforce can access safe, high-quality child care. Without immediate action to maintain the supply of home-based child care, our near term efforts to rebuild the economy will likely be stalled. |
FNDN | ||
Mozilla | COVID-19 Solutions Fund | Rolling | As part of the COVID-19 Solutions Fund, we will accept applications that are hardware (e.g., an open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D printers who can print parts for that open source ventilator), as well as software that solves for secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation). | FNDN |
Chan Zuckerberg Initiative |
CZI COVID-19 Response | Rolling | Through our mission of supporting the science and technology that will make it possible to cure, prevent, or manage all diseases by the end of this century — we are already making an impact in helping scientists and researchers on the frontlines of this outbreak. The work of CZI’s team is aimed at leveraging open science, technology, and collaboration to accelerate our shared understanding of COVID-19. And in collaboration with our partners and across our network of grantees, CZI is helping fight this virus by increasing access to testing, genomic sequencing, research, community support, and more. | FNDN |
Novartis |
Novartis COVID-19 Response Fund | To be announced | Novartis today announced a broad set of measures to support the global response to the COVID-19 pandemic. These measures include the creation of a global fund to support communities around the world impacted by the COVID-19 pandemic as well as the company’s decision to join two key cross-industry R&D initiatives. | FNDN |
MusiCares | Rolling |
To help address the concerns of the industry during this time, we have expanded our services to include lost income due to the cancellation of scheduled gigs or performances due to Coronavirus/COVID-19 precautionary measures. |
FNDN | |
Bill & Melinda Gates Foundation | To be announced |
The Bill & Melinda Gates Foundation, Wellcome and Mastercard today committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Currently, there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on COVID-19. |
FNDN | |
Patient-Centered Outcomes Research Institute (PCORI) | Rolling |
PCORI seeks investigator-initiated proposals to address the COVID-19 public health crisis through enhancements of currently funded PCORI research awards. |
FNDN | |
Rolling |
A total of $20 million in Google Cloud research credits will be provided for leveraging Google’s computing capabilities and infrastructure to study therapies, vaccines, etc. |
FNDN | ||
Amgen Foundation | Rolling |
Amgen has announced an open donation request program providing direct cash grants as well as lab supplies and equipment pertaining to COVID-19 relief; non-profits, IHEs, and health providers are welcome to apply. |
FNDN | |
CETF |
Research for COVID-19 Treatments | Rolling |
Topics: CETF seeks research funding to find an existing drug or drug combination that, when given early, can reduce COVID-19 hospitalization and fatality rates by 75% or more |
FNDN |
West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) |
West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) |
Rolling |
Topics: Pediatric medical device development or adaptation to manage the impact of COVID-19 on children |
FNDN |
Johnson & Johnson |
Topics: Proposals should address one or more of the following topics:
|
FNDN | ||
23andMe |
23andMe Research Innovation Collaborations Program for COVID-19 |
Rolling |
23andMe is now considering proposals focused on COVID-19. These proposals can include studies of outcomes, comorbidities, health disparities, and impacts of policies implemented to address the pandemic. If your proposal is related to COVID-19, please be sure to indicate this in your application. We are anticipating a high volume of COVID-19-related proposals, and our team of scientific reviewers is committed to selecting proposals where 23andMe’s participation will uniquely advance our understanding of this disease and the health of those impacted. |
FNDN |
Women’s History Network |
This supports historians of women who are suffering financial hardship because of the coronavirus. A total of eight awards, worth £400 each, are available. |
FNDN | ||
Spanish Ministry of Science and Innovation |
Solicitud Urgente de Expresiones de Interés para la Financiación Extraordinaria de Proyectos de Investigación sobre el SARS-CoV-2 y la Enfermedad COVID-19 (Spanish) |
Rolling |
Topics:
|
INTL |
Partnership for Advanced Computing in Europe |
|
This enables researchers to access computing resources to contribute to the mitigation of the impact of the COVID-19 pandemic. Access will be awarded for between three and six months and sized from 30 to 50 million core hours. |
INTL | |
Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) |
Emergency Action Projects to Combat the Effects of Covid-19 – FAPERJ / SES Partnership – 2020 |
Rolling |
Topics:
|
INTL |
UK Research and Innovation |
|
Rolling, through 04/01/2021 |
Topics:
|
INTL |
National Research Council Canada |
National Research Council Industrial Research Assistance Program (NRC IRAP) |
Topics: Development of COVID-19 solutions for health care workers and public health officials Due Dates: None; applicants directly contact an Industrial Technology Advisor at NRC |
INTL | |
National Research Council Canada |
11/17/2020 |
The National Research Council of Canada (NRC), in collaboration with Environment & Climate Change Canada (ECCC), Health Canada (HC), and Natural Resources Canada (NRCan), is seeking solutions for the manufacture of compostable disposable surgical masks and compostable disposable respirators to be used by healthcare workers. Topics: The proposed solution must:
|
INTL | |
European Space Agency |
Space Based Services-Applications Addressing COVID-19 Outbreak |
11/15/2020 |
The European Space Agency (ESA) is soliciting proposals to facilitate the quick integration and deployment of concrete and sustainable solutions to the COVID-19 pandemic that will make use of the different advantages provided by space-based products and services. Proposed solutions should alleviate the negative impacts of COVID-19 and associated containment measures and also help to improve preparedness for future outbreaks. At least one space asset must play a meaningful role in the proposed solution. Topics: Examples of application areas for the theme Healthcare:
Examples of application areas for the theme Education:
|
INTL |
European Space Agency |
01/15/2021 |
Topics: The proposed activity shall involve the use of some space technologies (i.e., satellite communications, satellite navigation, images from Earth Observation satellites, technologies related to human space flight). The proposed activity shall include a deployment of the solution and, wherever possible, a pilot utilization of the solution, to be performed within the UK health system. |
INTL | |
Malta Council for Science and Technology and Malta Enterprise Corporation |
|
Rolling, through 11/30/2020 |
Topics:
|
INTL |
Department of Health and Social Care including NIHR |
Travel and subsistence funding to support LMIC engagement during the COVID-19 outbreak |
12/31/2020 |
This provides travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to COVID-19 in low and middle-income countries. Funding covers travel, accommodation and meals. |
INTL |
United Kingdom Government |
TechForce19 – deploy technology to help vulnerable people isolated by COVID-19 |
03/31/2021 |
NHSX invites expressions of interest for the TechForce19 call. This enables innovators to test solutions that can support the elderly, vulnerable and self-isolating as COVID-19 continues to spread. The competition is aimed at helping in the community rather than seeking solutions that are trying to solve clinical problems or require integration with NHS systems. |
INTL |